UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry

Lung cancer (Amsterdam, Netherlands), 2020-02, Vol.140, p.107-112

2020

Volltextzugriff (PDF)

Treatment and survival of patients with EGFR -mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis

Lung cancer (Amsterdam, Netherlands), 2015-09, Vol.89 (3), p.255-261

2015

Volltextzugriff (PDF)

The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2020-11, Vol.149, p.68-77

2020

Volltextzugriff (PDF)

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

Lung cancer (Amsterdam, Netherlands), 2014-04, Vol.84 (1), p.86-91

2014

Volltextzugriff (PDF)

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET

Lung cancer (Amsterdam, Netherlands), 2017-05, Vol.107, p.1-13

2017

Volltextzugriff (PDF)

The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-07, Vol.133, p.130-135

2019

Volltextzugriff (PDF)

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.249-254

2015

Volltextzugriff (PDF)

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

Lung cancer (Amsterdam, Netherlands), 2019-04, Vol.130, p.179-186

2019

Volltextzugriff (PDF)

The impact of a pathologist’s personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-04, Vol.166, p.143-149

2022

Volltextzugriff (PDF)

Costs of non-small cell lung cancer in the Netherlands

Lung cancer (Amsterdam, Netherlands), 2016-01, Vol.91, p.79-88

2016

Volltextzugriff (PDF)

The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy – a nationwide cohort study

Lung cancer (Amsterdam, Netherlands), 2024-05, Vol.191, p.107792, Article 107792

2024

Volltextzugriff (PDF)

The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-11, Vol.161, p.141-151

2021

Volltextzugriff (PDF)

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Lung cancer (Amsterdam, Netherlands), 2019-12, Vol.138, p.102-108

2019

Volltextzugriff (PDF)

SUVmax during 18FDG-PET scanning in small cell lung cancer: Similar information as in non-small cell lung cancer?

Lung cancer (Amsterdam, Netherlands), 2012-04, Vol.76 (1), p.67-71

2012

Volltextzugriff (PDF)

Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective

Lung cancer (Amsterdam, Netherlands), 2024-10, Vol.196, p.107950, Article 107950

2024

Volltextzugriff (PDF)

Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses

Lung cancer (Amsterdam, Netherlands), 2018-10, Vol.124, p.130-134

2018

Volltextzugriff (PDF)

Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma

Lung cancer (Amsterdam, Netherlands), 2021-10, Vol.160, p.44-49

2021

Volltextzugriff (PDF)

Second primary lung cancers following a diagnosis of primary head and neck cancer

Lung cancer (Amsterdam, Netherlands), 2015-04, Vol.88 (1), p.94-99

2015

Volltextzugriff (PDF)

The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment

Lung cancer (Amsterdam, Netherlands), 2003-02, Vol.39 (2), p.151-157

2003

Volltextzugriff (PDF)

Brigatinib in crizotinib-refractory ALK+ non-small cell lung cancer (NSCLC): efficacy updates and exploratory analysis of target lesion response by baseline brain lesion status in the ALTA Trial

Lung cancer (Amsterdam, Netherlands), 2019-01, Vol.127, p.S30-S31

2019

Volltextzugriff (PDF)

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib

Lung cancer (Amsterdam, Netherlands), 2016-03, Vol.93, p.20-27

2016

Volltextzugriff (PDF)

Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions

Lung cancer (Amsterdam, Netherlands), 2005-06, Vol.48 (3), p.299

2005

Volltextzugriff (PDF)

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

Lung cancer (Amsterdam, Netherlands), 2005-10, Vol.50 (1), p.91-96

2005

Volltextzugriff (PDF)

CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasone

Lung cancer (Amsterdam, Netherlands), 2008-04, Vol.60 (1), p.57-61

2008

Volltextzugriff (PDF)

Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer

Lung cancer (Amsterdam, Netherlands), 2003-05, Vol.40 (2), p.165-172

2003

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieLung Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Oncology
(23)
Respiratory System
(23)
Science & Technology
(23)
Humans
(19)
Female
(17)
Male
(17)
Middle Aged
(16)
Aged
(15)
Carcinoma, Non-Small-Cell Lung - Pathology
(10)
Adult
(9)
Biological And Medical Sciences
(9)
Hematology, Oncology And Palliative Medicine
(9)
Lung Neoplasms - Pathology
(9)
Medical Sciences
(9)
Pulmonary/respiratory
(9)
Aged, 80 And Over
(8)
Neoplasm Staging
(8)
Pneumology
(8)
Tumors Of The Respiratory System And Mediastinum
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(34)
Ingenta
(34)
Elsevier ScienceDirect Journals
(34)
MEDLINE
(19)
IngentaConnect Journals
(1)

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry

Treatment and survival of patients with EGFR -mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis

The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET

The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

The impact of a pathologist’s personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer

Costs of non-small cell lung cancer in the Netherlands

The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy – a nationwide cohort study

The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

SUVmax during 18FDG-PET scanning in small cell lung cancer: Similar information as in non-small cell lung cancer?

Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective

Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses

Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma

Second primary lung cancers following a diagnosis of primary head and neck cancer

The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment

Brigatinib in crizotinib-refractory ALK+ non-small cell lung cancer (NSCLC): efficacy updates and exploratory analysis of target lesion response by baseline brain lesion status in the ALTA Trial

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib

Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasone

Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer

Aktive Filter

Suchergebnisse filtern